Fig. 7
From: The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice
The effect of Empagliflozin on functional recovery after stroke in non-T2D mice. Forepaw grip strength of non-T2D mice treated with vehicle (SD-VH) or daily treatment with 10 mg/kg Empagliflozin p.o. (SD-E) after stroke shown as plotted curve. Data are presented as mean ± SD. Statistical significance was calculated using two-way repeated measures ANOVA followed by Benjamini, Krieger and Yekutieli multiple comparisons test and results were considered significant when p < 0.05. SD-VH n = 7, SD-E n = 7